[Lys12(111In-BnDTPA-Ahx)]exendin-4

N/A

Report date: 2025/11/20 16:03:55

NME

Base Information

Drug Name[Lys12(111In-BnDTPA-Ahx)]exendin-4

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsPancreatic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKyoto University

China Registration ClassN/A

Develop Information

Active CompaniesKyoto University

Inactive CompaniesN/A

Active IndicationsPancreatic Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A